|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ROBERT L. EHRLICH, JR., Governor
|
|
S.B. 333
|
|
|
|
|
|
|
|
|
|
|
|
|
(III) (II) THE DESIGN AND IMPLEMENTATION OF AN ONGOING
EVALUATION COMPONENT OF THE PROGRAM.
21-2A-04.
(A) THE SECRETARY SHALL APPOINT A MULTIDISCIPLINARY CONSULTATION
TEAM WITHIN THE PROGRAM.
(B) THE MULTIDISCIPLINARY CONSULTATION TEAM SHALL REFLECT THE
DIVERSITY AND BALANCE OF PERSPECTIVES REPRESENTED ON THE ADVISORY
BOARD.
(B) (C) THE MULTIDISCIPLINARY CONSULTATION TEAM SHALL CONSIST OF:
(1) PROGRAM STAFF;
(2) MEMBERS OF THE BOARD; AND
(3) ANY CONSULTANTS THAT THE SECRETARY DETERMINES WILL
PROVIDE BROAD EXPERIENCE IN PAIN MANAGEMENT, SUBSTANCE ABUSE, AND
PRESCRIPTION DRUG DIVERSION HELP ACHIEVE THE DIVERSITY AND BALANCE OF
PERSPECTIVES REPRESENTED ON THE ADVISORY BOARD.
(C) (D) IN ACCORDANCE WITH REGULATION, THE MULTIDISCIPLINARY
CONSULTATION TEAM SHALL ASSIST A FEDERAL LAW ENFORCEMENT AGENCY, A
STATE OR LOCAL LAW ENFORCEMENT AGENCY, OR A LICENSING ENTITY THAT HAS
RECEIVED PRESCRIPTION MONITORING DATA FROM THE PROGRAM IN
INTERPRETING THE DATA AND CONSIDERING WHETHER THE DATA, IN THE CONTEXT
OF THE NATURE OF A PRESCRIBER'S OR A DISPENSER'S PRACTICE, A PATIENT'S
MEDICAL CONDITION, OR ANY OTHER RELEVANT FACTS, SUGGEST THE NEED FOR
FURTHER INVESTIGATION.
21-2A-05.
(A) FOR EACH MONITORED PRESCRIPTION DRUG THAT IS DISPENSED, A
DISPENSER SHALL SUBMIT TO THE PROGRAM INFORMATION SPECIFIED BY THE
SECRETARY, INCLUDING:
(1) A PATIENT IDENTIFIER;
(2) THE PRESCRIPTION DRUG DISPENSED;
(3) THE DATE OF DISPENSING;
(4) THE QUANTITY DISPENSED;
(5) THE PRESCRIBER; AND
(6) THE PHARMACY FROM WHICH THE DRUG IS DISPENSED; AND
(7) THE PRESCRIBER'S DIAGNOSIS CODE, IF SUCH CODE IS PART OF THE
ELECTRONIC RECORD CREATED BY THE DISPENSER.
|
|
|
|
|
|
|
|
|
|
- 3027 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
